Residual effect after oral bisphosphonate treatment and healthy adherer effects—the Swedish adherence register analysis (SARA)

Persistence and compliance of medications used in the treatment of osteoporosis – analysis using a large scale, representative, longitudinal German database

(2012) Volker Ziller et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA)

(2011) E. Landfeldt et al.   OSTEOPOROSIS INTERNATIONAL

GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates

(2011) P. Hadji et al.   OSTEOPOROSIS INTERNATIONAL

Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fractures

(2010) Kristine E. Ensrud et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

(2010) B. Jönsson et al.   OSTEOPOROSIS INTERNATIONAL

Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden

(2008) Ström Oskar et al.   Acta Orthopaedica

Anti-resorptives in the management of osteoporosis

(2008) Paul D. Miller   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Bisphosphonates: how do they work?

(2008) Socrates E. Papapoulos   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates

(2008) Arlene M Gallagher et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday

(2008) J. R. Curtis et al.   OSTEOPOROSIS INTERNATIONAL